Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of Obstetrics and Gynecology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
J Gynecol Oncol. 2023 May;34(3):e41. doi: 10.3802/jgo.2023.34.e41. Epub 2023 Jan 31.
To apply the International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system to all patients who underwent trachelectomy in our previous study and to update the oncologic and obstetric results.
We retrospectively reviewed the medical records of patients in whom abdominal trachelectomy was attempted between June 2005 and September 2021. The FIGO 2018 staging system for cervical cancer was applied to all patients.
Abdominal trachelectomy was attempted for 265 patients. Trachelectomy was converted to hysterectomy in 35 patients, and trachelectomy was completed successfully in 230 (conversion rate: 13%). Applying the FIGO 2018 staging system, 40% of the patients who underwent radical trachelectomy had stage IA tumors. Among 71 patients who had tumors measuring ≥2 cm, 8 patients were classified as stage IA1 and 14 as stage IA2. Overall recurrence and mortality rates were 2.2% and 1.3%, respectively. One hundred twelve patients attempted to conceive after trachelectomy; 69 pregnancies were achieved in 46 patients (pregnancy rate: 41%). Twenty-three pregnancies ended in first-trimester miscarriage, and 41 infants were delivered between gestational weeks 23 and 37; 16 were deliveries at term (39%) and 25 were premature deliveries (61%).
This study suggested that patients judged to be ineligible for trachelectomy and patients receiving overtreatment will continue to appear using the current standard eligibility criteria. With the revisions to the FIGO 2018 staging system, the preoperative eligibility criteria for trachelectomy, which were based on the FIGO 2009 staging system and tumor size, should be changed.
将国际妇产科联合会(FIGO)2018 分期系统应用于我们之前研究中接受过宫颈管切除术的所有患者,并更新肿瘤学和产科结果。
我们回顾性分析了 2005 年 6 月至 2021 年 9 月期间尝试行腹式宫颈管切除术的患者的病历。所有患者均采用 FIGO 2018 宫颈癌分期系统。
共尝试行腹式宫颈管切除术 265 例。35 例患者中转子宫切除术,230 例患者成功完成宫颈管切除术(中转率:13%)。采用 FIGO 2018 分期系统,行根治性宫颈管切除术的患者中有 40%为 IA 期肿瘤。在 71 例肿瘤直径≥2cm 的患者中,8 例为 IA1 期,14 例为 IA2 期。总复发率和死亡率分别为 2.2%和 1.3%。121 例患者在宫颈管切除术后尝试妊娠,46 例患者(妊娠率:41%)共 69 次妊娠。23 次妊娠发生于孕早期流产,41 例婴儿在孕 23 周至 37 周分娩,16 例为足月产(39%),25 例为早产(61%)。
本研究表明,目前的标准纳入标准可能导致判断为不适合行宫颈管切除术的患者和过度治疗的患者继续出现。随着 FIGO 2018 分期系统的修订,基于 FIGO 2009 分期系统和肿瘤大小的宫颈管切除术术前纳入标准应进行改变。